Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B <i>vs</i> metabolic dysfunction-associated steatotic liver disease patients
Article 2025 en
Authors
XL
Xueqi Li
CG
Cheng Guang-wen
IA
Iwaki Akiyama
Abstract
1 min read
The AC could effectively discriminate the degree of steatosis in both the CHB and MASLD groups. In the MASLD group, when combined with blood biochemical parameters, AC exhibited better predictive ability for moderate to severe steatosis.
Koen C. van Son, L.C. te Nijenhuis-Noort, Sebastiaan C. Boone, Dennis O. Mook‐Kanamori, Adriaan G. Holleboom, Paul R. Roos, Hildo J. Lamb, Gabrielle Alblas, Minneke J. Coenraad, Frits R. Rosendaal, Renée de Mutsert, Maarten E. Tushuizen
David M. Smadja, David M. Smadja, Richard Chocron, Richard Chocron, Nadia Rivet, Nadia Rivet, Sofia Ortuno, Sofia Ortuno, Coralie L. Guérin, Coralie L. Guérin, Jean‐Luc Diehl, Jean‐Luc Diehl
Discussion(0)
No comments yet. Be the first to comment.